With that in mind, let's take a closer look at Sequenom's business and see what CAPS investors are saying about the stock right now.
Sequenom facts
|
Headquarters (Founded)
|
San Diego (1994)
|
|
Market Cap
|
$191.4 million
|
|
Industry
|
Life sciences tools and services
|
|
Trailing-12-Month Revenue
|
$39.2 million
|
|
Management
|
Chairman/Interim CEO Dr. Harry Hixson, Jr.
Interim CFO Paul Maier
|
|
Compound Annual Revenue Growth (Over Past 3 Years)
|
16.2%
|
|
Cash / Debt
|
$50.1 million / $3.5 million
|
|
Competitors
|
Illumina (Nasdaq: ILMN)
Beckman Coulter (NYSE: BEC)
|
|
CAPS Members Bullish on SQNM Also Bullish on
|
General Electric (NYSE: GE)
Apple (Nasdaq: AAPL)
Citigroup (NYSE: C)
|
|
CAPS Members Bearish on SQNM Also Bearish on
|
AIG (NYSE: AIG)
|
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
On CAPS, 91% of the 634 members who have rated Sequenom believe the
stock will outperform the S&P 500 going forward. These bulls
include IdahoAve and All-Star mrindependent, who is ranked in the top 2% of our community.
Late last month, IdahoAve tapped Sequenom as a speculative bet to recover from its scandalous situation:
"I am gambling with this one. I am hoping the mishandlings in the
Trisomy 21 test were due to incompetent oversight, rather than
inadequate science."
In a pitch from last week, mrindependent expands on that sentiment:
Apparently, Sequenom's reported success for
non-invasive prenatal testing was based on improperly supervised
studies. … Based on the people involved, the theoretical underpinnings
and on the promising (but suspect) data delivered so far, I believe
that Sequenom has a better than even chance of eventually
commercializing its tests (or selling itself to a larger player). If
the tests are indeed viable, this company will be worth billions
compared to its current market cap of $200 million. In summary, I think
reward outweighs risk in this highly speculative stock.
What do you think about Sequenom, or any other stock for that
matter? Make your voice heard on Motley Fool CAPS today. The CAPS
community is waiting to hear your opinions. CAPS is 100% free, so get started!
© 2009 UCLICK L.L.C.
Post new comment